𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Cost-effectiveness of different strategies of cytomegalovirus (CMV) prophylaxis in recipients of orthotopic liver transplantation (OLT)

✍ Scribed by Das, A

Book ID
122351166
Publisher
Elsevier Science
Year
1998
Tongue
English
Weight
161 KB
Volume
114
Category
Article
ISSN
0016-5085

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Cost-effectiveness of different strategi
Cost-effectiveness of different strategies of cytomegalovirus prophylaxis in orthotopic liver transplant recipients
✍ Ananya Das πŸ“‚ Article πŸ“… 2000 πŸ› John Wiley and Sons 🌐 English βš– 95 KB

Cytomegalovirus (CMV) is an important cause of morbidity and mortality in liver transplant recipients and several different strategies of CMV chemoprophylaxis are in practice. A cost-effective analysis was performed to compare these strategies. A hypothetical cohort of liver transplant recipients wa

Question of using valganciclovir for cyt
Question of using valganciclovir for cytomegalovirus (CMV) infection prophylaxis in post–liver transplant recipients
✍ Ashok Jain; Ravi Mohanka; Mark Orloff; Peter Abt; Charlotte Ryan; Adel Bozorgzad πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 46 KB

We read the article by Park et al. with great interest. 1 The authors retrospectively studied the efficacy of low-dose oral valganciclovir (n Ο­ 49) compared with the standard dose of ganciclovir (n Ο­ 60) for the prevention of cytomegalovirus (CMV) disease in adult liver transplant recipients. The au